Biosimilars MarketForecast – 2014 To 2022

In-depth analysis of the market segments that will showcase the greatest growth potential

Information about the technological advancements influence the growth of the global market

Extensive analysis of the key players dominating the competitive landscape of this market

Browse the report : Biosimilars Market

Key Benefits Of The Report

The biosimilars market offers many growth opportunities and driving factors as compared to the restraining factors. It is stated by various research scientists that development of biosimilars will drastically reduce the price of the pharmaceutical drugs. A large number of key companies such as Hospira, Inc., Teva Pharmaceutical, Amgen, and others are in constant efforts to develop biosimilars and are rigorously increasing their research & development expenses on clinical trials to introduce novel biosimilars, driving the market growth. Amgen, Inc. has a strong research pipeline (phase III molecule) for the biosimilar products, such as ABP 501, ABP 980, and ABP 215. The demand for biosimilars is also expected to increase due to the rise in the incidences of the diseases such as cancer, cardiovascular diseases, and such others. For these diseases, biosimilars have proven a promising option for the disease diagnosis and mitigation. Other factors such as rising number of off-patented drugs, positive result of many biosimilar clinical trials and others drive the market growth to a great extent. However, a strict regulatory framework for the biosimilar manufacturers to develop these products restr

Key Premium Industry Insights

Microeconom

ic Indicat

ors

Mesoeconom

ic Indicat

ors

Macroecono

mic Indicat

ors

Data Collection & Analys

is The research methodology for Scalar Market Research’s

Biosimilars market report utilizes a combination of top-down and bottom-up research formats.

Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

Browse the report : Biosimilars Market

Research Methodology

Market Segmentation

Biosimilars Market, by Product Types Recombinant Non-Glycosylated Proteins Recombinant Glycosylated Proteins Recombinant Peptides

Biosimilars Market, by Applications Oncology Blood Disorders Infectious Diseases Autoimmune Diseases Others

Key Market Players Novartis International AG Stud Arzneimittel AG Amgen Inc. Pfizer Inc. Astra Zeneca plc Teva Pharmaceuticals Industries Ltd. Biocon Ltd.

Find out more about our services at : www.scalarmarketresearch.com

Contact :Mr. Rahul Ganju

8770 W Bryn Mawr Ave.,Suite 1300

Chicago, IL 60631 Tel. : +1-800-213-5170 (U.S./Canada Toll-free) Email : sales@scalarmarketresearch.com

Follow us on LinkedIn : https://www.linkedin.com/company/scalar-market-research

Contact Info

Other Reports :

1. Stem Cell Therapy Market2. In Vitro Diagnostics Market3. Synthetic Biology Market

Thank You